Orthopedic Biomaterials Market Size and Growth Analysis Report by Product (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics), Material Class (Metal, Non-Metal), Application (Joint Replacement, Fracture Fixation, Tissue Fixation, Implant Surgery, Viscosupplementation), End User (Hospitals & Clinics, Ambulatory Surgical Centers) – Industry Growth Forecast to 2030

Market Overview

The global orthopedic biomaterials market generated revenue of $14.2 billion in 2021, and its size will advance at a CAGR of 9.5% during 2021–2030, to reach $32.2 billion by 2030. The reconstructive joint replacements category held the largest market share in 2021, with revenue of $4.02 billion, and it would grow at a significant CAGR, of 9.2%, during the forecast period. This is because the prevalence of severe joint damage and late-stage osteoarthritis is rapidly increasing.

Furthermore, the increasing demand for next-generation orthopedic biomaterials that can be custom-made to fit the needs of specific operations has fueled the worldwide market expansion. In this regard, the rising number of orthopedic operations, such as joint arthroplasty, viscosupplementation, and joint reconstruction, is Essentially contributing to the market's expansion.

In 2021, the hospitals category accounted for the largest share of the market, of around 41.7%. In the majority of the nations, the number of hospital admissions and patient visits for orthopedic procedures has increased significantly over the last few decades. Patients usually choose to be treated at hospitals since modern therapeutic methods are accessible here.

Moreover, ambulatory surgery centers, or ASCs, have the second-largest share. They are modern healthcare facilities that provide same-day care, including diagnostic and therapeutic procedures, without requiring hospital admission.

Non-Metal Category To Witness Faster Growth

The non-metal category, consisting of ceramics and polymers, held the major share, of 59.7%, in 2021, and it is expected to register the higher CAGR, of 9.9%, during the forecast period. This is due to the rising use of ceramics in hard tissue restoration in various procedures, as well as the widespread use of polymers as bone cement and load-bearing surfaces in total joint arthroplasties. Moreover, the rising volume of spine surgeries and interbody fusion procedures will drive the consumption of non-metallic orthopedic biomaterials in the coming years.

Furthermore, a rise in the use of synthetic cages and pedicle screws during fixation operations is propelling the orthopedic biomaterials market growth. The goal of using these products is to increase the fusion rate of allografts. Furthermore, the availability of sophisticated conventional and biopolymers for different applications, such as bio-resorbable and orthobiologic tissue fixation, has increased the polymer demand globally.

The orthobiologics category is predicted to develop significantly during the forecast period due to an increase in the number of bone repair and reconstruction procedures globally, as a result of the rising incidence of obesity and trauma. According to statistics, around one million people die each year as a result of road traffic accidents throughout the world, with low- and middle-income nations accounting for more than 90% of the deaths.

Rapid Surge in Prevalence of Musculoskeletal Ailments

The rise in the burden of musculoskeletal problems is projected to boost the orthopedic biomaterials market growth. Musculoskeletal diseases are the primary causes of disability globally, as per research, with these disabilities affecting 20–30% of the population. Fractures, swelling, and soreness in the joints, ligaments, and tendons are common musculoskeletal problems that result in restricted mobility.

The prevalence of musculoskeletal disorders is known to rise with age. As a result, the UN’s Sustainable Development Goals and the Decade of Healthy Ageing 2021–2030 have called for stronger worldwide attention and action on musculoskeletal health, with a special focus on the elderly.

Rising Need for Next-Generation Orthopedic Biomaterials

Market players are focused on offering the greatest quality of orthopedic biomaterial goods and treatments, to lower the treatment cost and need for retreatment for patients. Furthermore, the advancements in the biomaterial technology have increased the success rate of orthopedic surgeries across the world. The presence of large businesses in the industry plays a significant role in improving the outcomes for patients with bone-and-joint problems, at the same time helping these companies expand their global footprint.

According to one of the published reports, there was to be a significant drop in revision rates of hip and knee implants in 2021 as a result of registry creation and identification of the best practices. Moreover, research has found that the implantation success rate is, likewise, high, which is one of the primary reasons driving the need for medical implants. Thus, throughout the projection period, the improvement in surgical outcomes is likely to boost the growth of the worldwide orthopedic biomaterials market.

Explore more about this report - Request free sample pages

Tremendous Growth Being Seen in North America

North America led the market in 2021, and it is set to expand at an attractive CAGR in the coming years. This can be ascribed to a rise in the number of patients undergoing knee replacement and reconstruction and other treatments on their joints.

This is also attributable to the wide use of modern orthopedic products, as well as the presence of a significant number of biotechnology firms operating in the orthopedics space. The rapid adoption of enhanced solutions for implant load bearing and bone void filling is expected to propel the regional market even more. Furthermore, the market advance is being fueled by a well-established healthcare infrastructure, growing healthcare expenditure, and the high incidence of sports injuries in the U.S.

In addition, the APAC region is predicted to be the fastest-growing market, at a CAGR of 10.0%, in the coming years. The increasing burden of musculoskeletal disorders, including bone degenerative illnesses, in developing countries is one of the key reasons driving the regional market. In addition, the surging healthcare expenditure, combined with the improvements in the healthcare infrastructure, is likely to have a strong positive impact on the market in this region.

To Increase Market Share, Companies Involved in Several Strategic Developments

The market has the presence of several key players, who, in recent years, have been involved in various strategic developments, in order to stay ahead of their competitors. For instance, in March 2022, Evonik introduced osteoconductive VESTAKEEP Fusion, a filament made from PEEK, for 3D-printed implants.

Key Players in Global Orthopedic Biomaterials Market Are:

• Stryker Corp
• Zimmer Biomet Holdings Inc.
• Medtronic Plc
• CAM Bioceramics B.V.
• Nobel Biocare Holding AG
• Exactech Inc.
• Globus Medical Inc.
• Invibio Ltd.

Global Orthopedic Biomaterials Market Size Breakdown by Segment

The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Product

• Reconstructive Joint Replacements
• Spinal Implants
• Dental Implants 
• Trauma 
• Orthobiologics 

Based on Material Class

• Metal
• Non-Metal

Based on Application

• Joint Replacement
• Fracture Fixation
• Tissue Fixation
• Implant Surgery
• Viscosupplementation

Based on End User

• Hospitals & Clinics
• Ambulatory Surgical Centers

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa